Toll Free: 1-888-928-9744
Published: Aug, 2017 | Pages:
106 | Publisher: JP Research
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
The global Rotavirus Vaccine market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%. This report, with focus on top players in the global and Japan, studies the Rotavirus Vaccine market's development status and future trend in the global and Japan. It splits Rotavirus Vaccine market by type and by applications to fully and deeply research and reveal market profile and prospect. The major players include Merck (DE) GSK (UK) Sanofi (FR) ... Geographically, this report splits the Global market into the following regions: Asia Pacific Japan Tokyo Yokohama Osaka Nagoya Others China Korea India Others Europe France Germany United Kingdom Italy Russia Others North America United States Canada Latin America Brazil Mexico Others Southeast Asia Singapore Malaysia Vietnam Myanmar Thailand Indonesia Philippines Others Middle East & Africa Saudi Arabia Iran UAE Turkey Israel Egypt South Africa Others On the basis of product, the Rotavirus Vaccine market is primarily split into By Type Oral Others By Type 2 Live Attenuated Vaccine Inactivated Vaccine Key Applications Hospital Clinics Public Services Others
Table of Contents 2017-2022 Global and Japan Rotavirus Vaccine Market Analysis Report 1 Rotavirus Vaccine Overview 1.1 Product Overview and Scope of Rotavirus Vaccine 1.2 Global and Japan Rotavirus Vaccine Market by Applications/End Users 1.2.1 Japan Rotavirus Vaccine Sales (K Pcs) and Market Share Comparison by Applications (2012-2017) 1.2.1.1 Japan Rotavirus Vaccine Sales (K Pcs) and Market Share by Applications (2012-2017) 1.2.1.2 Japan Rotavirus Vaccine Sales Growth Rate (%) by Applications (2012-2017) 1.2.1.3 Market Drivers and Opportunities 1.2.2 Japan Rotavirus Vaccine Sales (K Pcs) and Market Share Comparison by Applications (2012-2017) 1.2.3 Global Rotavirus Vaccine Sales by Application (2012-2017) 1.2.3.1 Global Rotavirus Vaccine Sales (K Pcs) and Market Share by Applications (2012-2017) 1.2.3.2 Global Rotavirus Vaccine Sales Growth Rate (%) by Applications (2012-2017) 1.2.3.3 Market Drivers and Opportunities 1.2.4 Global Rotavirus Vaccine Sales (K Pcs) and Market Share Comparison by Applications (2012-2017) 1.2.5 Hospital 1.2.6 Clinics 1.2.7 Public Services 1.2.8 Others 1.3 Global and Japan Market Size (Sales and Revenue) of Rotavirus Vaccine (2012-2017) 1.3.1 Japan Market Size (Sales and Revenue) of Rotavirus Vaccine (2012-2017) 1.3.1.1 Japan Rotavirus Vaccine Sales (K Pcs) and Growth Rate (%) (2012-2017) 1.3.1.2 Japan Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2017) 1.3.2 Global Market Size (Sales and Revenue) of Rotavirus Vaccine (2012-2017) 1.3.2.1 Global Rotavirus Vaccine Sales (K Pcs) and Growth Rate (%) (2012-2017) 1.3.2.2 Global Rotavirus Vaccine Revenue (Million USD) and Growth Rate (2012-2017) 1.4 Global and Japan Classification of Rotavirus Vaccine by Type 1.4.1 Japan Rotavirus Vaccine Sales (K Pcs) and Market Share by Type (2012-2017) 1.4.2 Global Rotavirus Vaccine Sales (K Pcs) and Market Share by Type (2012-2017) 1.4.3 Japan Rotavirus Vaccine Revenue (Million USD) and Market Share by Type (2012-2017) 1.4.4 Global Rotavirus Vaccine Revenue (Million USD) and Market Share by Type (2012-2017) 1.4.5 Japan Rotavirus Vaccine Price (USD/Pcs) by Type (2012-2017) 1.4.6 Global Rotavirus Vaccine Price (USD/Pcs) by Type (2012-2017) 1.4.7 Japan Rotavirus Vaccine Sales Growth Rate (%) by Type (2012-2017) 1.4.8 Global Rotavirus Vaccine Sales Growth Rate (%) by Type (2012-2017) 1.4.9 Oral 1.4.10 Others 1.5 Global and Japan Classification of Rotavirus Vaccine by Type 2 1.5.1 Japan Rotavirus Vaccine Sales (K Pcs) and Market Share by Type 2 (2012-2017) 1.5.2 Global Rotavirus Vaccine Sales (K Pcs) and Market Share by Type 2 (2012-2017) 1.5.3 Japan Rotavirus Vaccine Revenue (Million USD) and Market Share by Type 2 (2012-2017) 1.5.4 Global Rotavirus Vaccine Revenue (Million USD) and Market Share by Type 2 (2012-2017) 1.5.5 Japan Rotavirus Vaccine Price (USD/Pcs) by Type 2 (2012-2017) 1.5.6 Global Rotavirus Vaccine Price (USD/Pcs) by Type 2 (2012-2017) 1.5.7 Japan Rotavirus Vaccine Sales Growth Rate (%) by Type 2 (2012-2017) 1.5.8 Global Rotavirus Vaccine Sales Growth Rate (%) by Type 2 (2012-2017) 1.5.9 Live Attenuated Vaccine 1.5.10 Inactivated Vaccine 2 Global and Japan Rotavirus Vaccine Market Competition by Players/Manufacturers 2.1 Japan Rotavirus Vaccine Market Competition by Players/Manufacturers 2.1.1 Japan Rotavirus Vaccine Sales and Market Share of Key Players/Manufacturers (2012-2017) 2.1.2 Japan Rotavirus Vaccine Revenue and Share by Players/Manufacturers (2012-2017) 2.1.3 Japan Rotavirus Vaccine Average Price (USD/Pcs) by Players/Manufacturers (2012-2017) 2.1.4 Japan Rotavirus Vaccine Market Competitive Situation and Trends 2.1.4.1 Japan Rotavirus Vaccine Market Concentration Rate 2.1.4.2 Japan Rotavirus Vaccine Market Share of Top 3 and Top 5 Players/Manufacturers 2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market 2.1.5 Japan Players/Manufacturers Rotavirus Vaccine Manufacturing Base Distribution, Sales Area, Product Types 2.2 Global Rotavirus Vaccine Market Competition by Players/Manufacturers 2.2.1 Global Rotavirus Vaccine Sales and Market Share of Key Players/Manufacturers (2012-2017) 2.2.2 Global Rotavirus Vaccine Revenue and Share by Players/Manufacturers (2012-2017) 2.2.3 Global Rotavirus Vaccine Average Price (USD/Pcs) by Players/Manufacturers (2012-2017) 2.2.4 Global Rotavirus Vaccine Market Competitive Situation and Trends 2.2.4.1 Global Rotavirus Vaccine Market Concentration Rate 2.2.4.2 Global Rotavirus Vaccine Market Share of Top 3 and Top 5 Players/Manufacturers 2.2.4.3 Mergers & Acquisitions, Expansion in Global Market 2.2.5 Global Players/Manufacturers Rotavirus Vaccine Manufacturing Base Distribution, Sales Area, Product Types 3 Global and Japan Rotavirus Vaccine Sales and Revenue by Regions (2012-2017) 3.1 Asia Pacific Rotavirus Vaccine Sales and Revenue by Regions (2012-2017) 3.1.1 Japan Rotavirus Vaccine Sales and Revenue (2012-2017) 3.1.1.1 Japan Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.1.1.2 Japan Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.1.1.3 Japan Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.1.2 China Rotavirus Vaccine Sales and Revenue (2012-2017) 3.1.2.1 China Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.1.2.2 China Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.1.2.3 China Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.1.3 Korea Rotavirus Vaccine Sales and Revenue (2012-2017) 3.1.3.1 Korea Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.1.3.2 Korea Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.1.3.3 Korea Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.1.4 India Rotavirus Vaccine Sales and Revenue (2012-2017) 3.1.4.1 India Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.1.4.2 India Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.1.4.3 India Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.1.5 Others Rotavirus Vaccine Sales and Revenue (2012-2017) 3.1.5.1 Others Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.1.5.2 Others Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.1.5.3 Others Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.2 Europe Rotavirus Vaccine Sales and Revenue by Regions (2012-2017) 3.2.1 France Rotavirus Vaccine Sales and Revenue (2012-2017) 3.2.1.1 France Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.2.1.2 France Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.2.1.3 France Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.2.2 Germany Rotavirus Vaccine Sales and Revenue (2012-2017) 3.2.2.1 Germany Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.2.2.2 Germany Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.2.2.3 Germany Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.2.3 United Kingdom Rotavirus Vaccine Sales and Revenue (2012-2017) 3.2.3.1 United Kingdom Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.2.3.2 United Kingdom Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.2.3.3 United Kingdom Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.2.4 Italy Rotavirus Vaccine Sales and Revenue (2012-2017) 3.2.4.1 Italy Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.2.4.2 Italy Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.2.4.3 Italy Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.2.5 Russia Rotavirus Vaccine Sales and Revenue (2012-2017) 3.2.5.1 Russia Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.2.5.2 Russia Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.2.5.3 Russia Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.2.6 Others Rotavirus Vaccine Sales and Revenue (2012-2017) 3.2.6.1 Others Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.2.6.2 Others Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.2.6.3 Others Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.3 North America Rotavirus Vaccine Sales and Revenue by Regions (2012-2017) 3.3.1 United States Rotavirus Vaccine Sales and Revenue (2012-2017) 3.3.1.1 United States Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.3.1.2 United States Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.3.1.3 United States Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.3.2 Canada Rotavirus Vaccine Sales and Revenue (2012-2017) 3.3.2.1 Canada Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.3.2.2 Canada Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.3.2.3 Canada Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.4 Latin America Rotavirus Vaccine Sales and Revenue by Regions (2012-2017) 3.4.1 Brazil Rotavirus Vaccine Sales and Revenue (2012-2017) 3.4.1.1 Brazil Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.4.1.2 Brazil Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.4.1.3 Brazil Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.4.2 Mexico Rotavirus Vaccine Sales and Revenue (2012-2017) 3.4.2.1 Mexico Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.4.2.2 Mexico Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.4.2.3 Mexico Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.4.3 Others Rotavirus Vaccine Sales and Revenue (2012-2017) 3.4.3.1 Others Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.4.3.2 Others Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.4.3.3 Others Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.5 Southeast Asia Rotavirus Vaccine Sales and Revenue by Regions (2012-2017) 3.5.1 Singapore Rotavirus Vaccine Sales and Revenue (2012-2017) 3.5.1.1 Singapore Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.5.1.2 Singapore Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.5.1.3 Singapore Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.5.2 Malaysia Rotavirus Vaccine Sales and Revenue (2012-2017) 3.5.2.1 Malaysia Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.5.2.2 Malaysia Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.5.2.3 Malaysia Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.5.3 Vietnam Rotavirus Vaccine Sales and Revenue (2012-2017) 3.5.3.1 Vietnam Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.5.3.2 Vietnam Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.5.3.3 Vietnam Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.5.4 Myanmar Rotavirus Vaccine Sales and Revenue (2012-2017) 3.5.4.1 Myanmar Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.5.4.2 Myanmar Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.5.4.3 Myanmar Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.5.5 Thailand Rotavirus Vaccine Sales and Revenue (2012-2017) 3.5.5.1 Thailand Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.5.5.2 Thailand Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.5.5.3 Thailand Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.5.6 Indonesia Rotavirus Vaccine Sales and Revenue (2012-2017) 3.5.6.1 Indonesia Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.5.6.2 Indonesia Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.5.6.3 Indonesia Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.5.7 Philippines Rotavirus Vaccine Sales and Revenue (2012-2017) 3.5.7.1 Philippines Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.5.7.2 Philippines Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.5.7.3 Philippines Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.5.8 Others Rotavirus Vaccine Sales and Revenue (2012-2017) 3.5.8.1 Others Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.5.8.2 Others Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.5.8.3 Others Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.6 Middle East & Africa Rotavirus Vaccine Sales and Revenue by Regions (2012-2017) 3.6.1 Saudi Arabia Rotavirus Vaccine Sales and Revenue (2012-2017) 3.6.1.1 Saudi Arabia Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.6.1.2 Saudi Arabia Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.6.1.3 Saudi Arabia Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.6.2 Iran Rotavirus Vaccine Sales and Revenue (2012-2017) 3.6.2.1 Iran Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.6.2.2 Iran Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.6.2.3 Iran Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.6.3 UAE Rotavirus Vaccine Sales and Revenue (2012-2017) 3.6.3.1 UAE Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.6.3.2 UAE Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.6.3.3 UAE Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.6.4 Turkey Rotavirus Vaccine Sales and Revenue (2012-2017) 3.6.4.1 Turkey Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.6.4.2 Turkey Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.6.4.3 Turkey Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.6.5 Israel Rotavirus Vaccine Sales and Revenue (2012-2017) 3.6.5.1 Israel Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.6.5.2 Israel Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.6.5.3 Israel Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.6.6 Egypt Rotavirus Vaccine Sales and Revenue (2012-2017) 3.6.6.1 Egypt Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.6.6.2 Egypt Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.6.6.3 Egypt Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.6.7 South Africa Rotavirus Vaccine Sales and Revenue (2012-2017) 3.6.7.1 South Africa Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.6.7.2 South Africa Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.6.7.3 South Africa Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 3.6.8 Others Rotavirus Vaccine Sales and Revenue (2012-2017) 3.6.8.1 Others Rotavirus Vaccine Sales (K Pcs) and Market Share (2012-2017) 3.6.8.2 Others Rotavirus Vaccine Revenue (Million USD) and Market Share (2012-2017) 3.6.8.3 Others Rotavirus Vaccine Price (USD/Pcs)(2012-2017) 4 Global and Japan Rotavirus Vaccine Players/Manufacturers Profiles and Sales Data 4.1 Merck (DE) 4.1.1 Company Basic Information, Manufacturing Base and Competitors 4.1.2 Rotavirus Vaccine Product Category, Application and Specification 4.1.2.1 Product A 4.1.2.2 Product B 4.1.3 Merck (DE) Rotavirus Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) 4.1.4 Main Business/Business Overview 4.2 GSK (UK) 4.2.1 Company Basic Information, Manufacturing Base and Competitors 4.2.2 Rotavirus Vaccine Product Category, Application and Specification 4.2.2.1 Product A 4.2.2.2 Product B 4.2.3 GSK (UK) Rotavirus Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) 4.2.4 Main Business/Business Overview 4.3 Sanofi (FR) 4.3.1 Company Basic Information, Manufacturing Base and Competitors 4.3.2 Rotavirus Vaccine Product Category, Application and Specification 4.3.2.1 Product A 4.3.2.2 Product B 4.3.3 Sanofi (FR) Rotavirus Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) 4.3.4 Main Business/Business Overview ... 5 Rotavirus Vaccine Manufacturing Cost Analysis 5.1 Rotavirus Vaccine Key Raw Materials Analysis 5.1.1 Key Raw Materials 5.1.2 Price Trend of Key Raw Materials 5.1.3 Key Suppliers of Raw Materials 5.1.4 Market Concentration Rate of Raw Materials 5.2 Proportion of Manufacturing Cost Structure 5.2.1 Raw Materials 5.2.2 Labor Cost 5.2.3 Manufacturing Expenses 5.3 Manufacturing Process Analysis of Rotavirus Vaccine 6 Industrial Chain, Sourcing Strategy and Downstream Buyers 6.1 Rotavirus Vaccine Industrial Chain Analysis 6.2 Upstream Raw Materials Sourcing 6.3 Raw Materials Sources of Rotavirus Vaccine Major Players/Manufacturers in 2016 6.4 Downstream Buyers 7 Marketing Strategy Analysis, Distributors/Traders 7.1 Marketing Channel 7.1.1 Direct Marketing 7.1.2 Indirect Marketing 7.1.3 Marketing Channel Development Trend 7.2 Market Positioning 7.2.1 Pricing Strategy 7.2.2 Brand Strategy 7.2.3 Target Client 7.3 Distributors/Traders List 8 Market Effect Factors Analysis 8.1 Technology Progress/Risk 8.1.1 Substitutes Threat 8.1.2 Technology Progress in Related Industry 8.2 Consumer Needs/Customer Preference Change 8.3 Economic/Political Environmental Change 9 Global and Japan Rotavirus Vaccine Market Size (Sales and Revenue) Forecast (2017-2022) 9.1 Global and Japan Rotavirus Vaccine Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022) 9.2 Global and Japan Rotavirus Vaccine Sales (K Pcs) Forecast by Type (2017-2022) 9.2.1 by Type 9.2.2 by Type 2 9.3 Global and Japan Rotavirus Vaccine Sales (K Pcs) Forecast by Application (2017-2022) 9.4 Global and Japan Rotavirus Vaccine Sales (K Pcs) Forecast by Regions (2017-2022) 10 Research Findings and Conclusion 11 Methodology and Data Source 11.1 Methodology/Research Approach 11.1.1 Research Programs/Design 11.1.2 Market Size Estimation 11.1.3 Market Breakdown and Data Triangulation 11.2 Data Source 11.2.1 Secondary Sources 11.2.2 Primary Sources 11.3 Disclaimer 11.4 Author List
List of Tables and Figures Figure Product Picture of Rotavirus Vaccine Table Japan Rotavirus Vaccine Sales (Million Units) Comparison by Applications (2012-2017) Figure Japan Sales Market Share (%) of Rotavirus Vaccine by Applications in 2016 Table Global Rotavirus Vaccine Sales (Million Units) Comparison by Applications (2012-2017) Figure Global Sales Market Share (%) of Rotavirus Vaccine by Applications in 2016 Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Clinics Examples Table Key Downstream Customer in Clinics Figure Public Services Examples Table Key Downstream Customer in Public Services Figure Others Examples Table Key Downstream Customer in Others Figure Oral Product Picture Figure Others Product Picture Figure Live Attenuated Vaccine Product Picture Figure Inactivated Vaccine Product Picture Table Merck (DE) Basic Information List Table Merck (DE) Rotavirus Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Table Merck (DE) Rotavirus Vaccine Sales Growth Rate (%)(2012-2017) Table Merck (DE) Rotavirus Vaccine Sales Market Share (%) in Japan (2012-2017) Figure Merck (DE) Rotavirus Vaccine Revenue Market Share (%) in Japan (2012-2017) Table GSK (UK) Basic Information List Table GSK (UK) Rotavirus Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Table GSK (UK) Rotavirus Vaccine Sales Growth Rate (%)(2012-2017) Table GSK (UK) Rotavirus Vaccine Sales Market Share (%) in Japan (2012-2017) Figure GSK (UK) Rotavirus Vaccine Revenue Market Share (%) in Japan (2012-2017) Table Sanofi (FR) Basic Information List Table Sanofi (FR) Rotavirus Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017) Table Sanofi (FR) Rotavirus Vaccine Sales Growth Rate (%)(2012-2017) Table Sanofi (FR) Rotavirus Vaccine Sales Market Share (%) in Japan (2012-2017) Figure Sanofi (FR) Rotavirus Vaccine Revenue Market Share (%) in Japan (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Rotavirus Vaccine Figure Manufacturing Process Analysis of Rotavirus Vaccine Figure Rotavirus Vaccine Industrial Chain Analysis Table Raw Materials Sources of Rotavirus Vaccine Major Players/Manufacturers in 2016 Table Major Buyers of Rotavirus Vaccine Table Distributors/Traders List Figure Japan Rotavirus Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022) Figure Japan Rotavirus Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Japan Rotavirus Vaccine Price (USD/Pcs) Trend Forecast (2017-2022) Figure Global Rotavirus Vaccine Sales (K Pcs) and Growth Rate (%) Forecast (2017-2022) Figure Global Rotavirus Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Global Rotavirus Vaccine Price (USD/Pcs) Trend Forecast (2017-2022) Table Japan Rotavirus Vaccine Sales (K Pcs) Forecast by Type (2017-2022) Table Global Rotavirus Vaccine Sales (K Pcs) Forecast by Type (2017-2022) Figure Japan Rotavirus Vaccine Sales (K Pcs) Forecast by Type (2017-2022) Figure Global Rotavirus Vaccine Sales (K Pcs) Forecast by Type (2017-2022) Figure Japan Rotavirus Vaccine Sales Volume Market Share Forecast by Type in 2017 Figure Global Rotavirus Vaccine Sales Volume Market Share Forecast by Type in 2017 Table Japan Rotavirus Vaccine Sales (K Pcs) Forecast by Application (2017-2022) Figure Japan Rotavirus Vaccine Sales Volume Market Share Forecast by Application (2017-2022) Figure Japan Rotavirus Vaccine Sales Volume Market Share Forecast by Application in 2017 Table Global Rotavirus Vaccine Sales (K Pcs) Forecast by Application (2017-2022) Figure Global Rotavirus Vaccine Sales Volume Market Share Forecast by Application (2017-2022) Figure Global Rotavirus Vaccine Sales Volume Market Share Forecast by Application in 2017 Table Japan Rotavirus Vaccine Sales (K Pcs) Forecast by Regions (2017-2022) Table Japan Rotavirus Vaccine Sales Volume Share Forecast by Regions (2017-2022) Figure Japan Rotavirus Vaccine Sales Volume Share Forecast by Regions (2017-2022) Table Global Rotavirus Vaccine Sales (K Pcs) Forecast by Regions (2017-2022) Table Global Rotavirus Vaccine Sales Volume Share Forecast by Regions (2017-2022) Figure Global Rotavirus Vaccine Sales Volume Share Forecast by Regions (2017-2022) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.